Dongkook Pharmaceutical: A New Promising Stock in the Hair Loss Treatment Market

He added that investors should prepare for profit-taking in sectors that have moved based on themes.

However, he explained that leading industries like semiconductors are expected to remain strong, and continued attention to these sectors is necessary.

He also urged attention to sectors related to U.S. investment. Following the gas turbine-related stocks, which were the first U.S. investment theme yesterday, the nuclear power sector emerged as the second.

Manager Kim Heung-tae analyzed that there are still materials remaining for U.S. investment sectors that are likely to emerge steadily, and advised that a strategy of preemptively buying into these industries would be effective.

Regarding Wonik Holdings, he mentioned that the first target price has already been achieved and judged that there is a high possibility of further upside from its current bottom-out position. He specifically anticipated that the highlighting of Wonik Robotics' (its subsidiary) robot technology would have a positive impact.

Accordingly, he recommended realizing profits on half of the holdings and holding the remaining half to maximize profits, with the second target price raised to ₩27,000.

Sungkwang Bend was also presented as a stock for which a holding strategy should be maintained. Manager Kim Heung-tae stated that Sungkwang Bend is considered a key beneficiary of LNG projects.

He analyzed that while nuclear power and gas turbines have been beneficiaries so far, the next U.S. investment sector is highly likely to be LNG projects, especially the Alaska project, and explained that Sungkwang Bend has strengths as a company related to fitting valves.

He also mentioned that G2 Power achieved its first target price with a rise of over 15%, analyzing that the current upward trend is not over. He stated that the ascending triangle pattern was confirmed in the chart analysis.

He particularly forecasted high long-term growth potential for the nuclear power sector, as new nuclear power plants are being built in the U.S. market and discussions for the acquisition of Westinghouse continue. Accordingly, he recommended realizing profits on half of G2 Power's holdings and holding the remaining half, with the second target price raised to ₩13,000.

Manager Kim Heung-tae stated that attention should be paid to the hair loss treatment market, which he has emphasized. Recently, Hyundai Pharm hit the upper limit, and JW Pharmaceutical also showed a sharp rise, which he explained is deeply related to the announcement of the U.S. guidelines for treating alopecia areata.

Many people in the U.S. suffer from hair loss, leading to the new announcement of the first treatment guidelines for alopecia areata in the U.S. These guidelines recommend intravenous steroids or oral steroids for patients aged 2 and older and do not include the use of topical steroids or minoxidil.

This heralds a new expansion of the hair loss treatment market and is expected to have a positive impact on related domestic companies. Manager Kim Heung-tae noted the potential for growth in related stocks, including Dongkook Pharmaceutical, in this context.